Effect of dextroamphetamine and methylphenidate on calcium and magnesium concentration in hyperactive boys. 1994

M E Schmidt, and M J Kruesi, and J Elia, and B G Borcherding, and R J Elin, and J M Hosseini, and K E McFarlin, and S Hamburger
Section on Clinical Pharmacology, National Institute of Mental Health, Bethesda, MD 20892, USA.

Levels of calcium in plasma, red blood cells, and mononuclear blood cells, levels of calcium in plasma, and the plasma calcium-to-magnesium ratio were measured at baseline and after 3 weeks of each drug phase of a double-blind, placebo-controlled study of methylphenidate and dextroamphetamine in hyperactive boys. Levels of magnesium in plasma were significantly higher after 3 weeks of dextroamphetamine treatment, and the calcium-to-magnesium ratio was significantly lower after 3 weeks of either drug compared with the baseline or placebo condition. There was no change in magnesium levels in red blood cells or mononuclear blood cells. These measures were obtained 30 minutes before the morning dose and at 9 a.m., 9:30 a.m., 10:30 a.m., 11:00 a.m., and noon on the last day of each 3-week phase. Analysis of variance revealed a drug effect on plasma magnesium and on the calcium-to-magnesium ratio but no drug x time interaction. Although these changes were not correlated with the time course of acute symptomatic response to stimulant therapy, the decrease in the ratio may be relevant to side effects and treatment resistance associated with stimulant use.

UI MeSH Term Description Entries
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D008297 Male Males
D008774 Methylphenidate A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE. Centedrin,Concerta,Daytrana,Equasym,Metadate,Methylin,Methylphenidate Hydrochloride,Phenidylate,Ritalin,Ritalin-SR,Ritaline,Tsentedrin,Hydrochloride, Methylphenidate,Ritalin SR
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D003913 Dextroamphetamine The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic. d-Amphetamine,Curban,Dexamfetamine,Dexamphetamine,Dexedrine,Dextro-Amphetamine Sulfate,DextroStat,Dextroamphetamine Sulfate,Oxydess,d-Amphetamine Sulfate,dextro-Amphetamine,Dextro Amphetamine Sulfate,Sulfate, Dextroamphetamine,d Amphetamine,d Amphetamine Sulfate,dextro Amphetamine
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine

Related Publications

M E Schmidt, and M J Kruesi, and J Elia, and B G Borcherding, and R J Elin, and J M Hosseini, and K E McFarlin, and S Hamburger
February 1974, Pediatrics,
M E Schmidt, and M J Kruesi, and J Elia, and B G Borcherding, and R J Elin, and J M Hosseini, and K E McFarlin, and S Hamburger
September 1979, The Journal of pediatrics,
M E Schmidt, and M J Kruesi, and J Elia, and B G Borcherding, and R J Elin, and J M Hosseini, and K E McFarlin, and S Hamburger
January 1977, The Journal of pediatrics,
M E Schmidt, and M J Kruesi, and J Elia, and B G Borcherding, and R J Elin, and J M Hosseini, and K E McFarlin, and S Hamburger
January 1984, Progress in neuro-psychopharmacology & biological psychiatry,
M E Schmidt, and M J Kruesi, and J Elia, and B G Borcherding, and R J Elin, and J M Hosseini, and K E McFarlin, and S Hamburger
December 1989, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
M E Schmidt, and M J Kruesi, and J Elia, and B G Borcherding, and R J Elin, and J M Hosseini, and K E McFarlin, and S Hamburger
January 1985, Psychopharmacology,
M E Schmidt, and M J Kruesi, and J Elia, and B G Borcherding, and R J Elin, and J M Hosseini, and K E McFarlin, and S Hamburger
August 2001, Journal of abnormal child psychology,
M E Schmidt, and M J Kruesi, and J Elia, and B G Borcherding, and R J Elin, and J M Hosseini, and K E McFarlin, and S Hamburger
July 1974, Psychophysiology,
M E Schmidt, and M J Kruesi, and J Elia, and B G Borcherding, and R J Elin, and J M Hosseini, and K E McFarlin, and S Hamburger
July 1993, Journal of child psychology and psychiatry, and allied disciplines,
M E Schmidt, and M J Kruesi, and J Elia, and B G Borcherding, and R J Elin, and J M Hosseini, and K E McFarlin, and S Hamburger
June 1980, Journal of abnormal child psychology,
Copied contents to your clipboard!